, World Health Organization. Global tuberculosis Report, 2018.

, Tuberculosis Coalition for Technical Assistance. International Standards for Tuberculosis Care (ISTC). The Hague: Tuberculosis Coalition for Technical Assistance, 2006.

H. Getahun, M. Harrington, R. O'-brien, and P. Nunn, Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes, Lancet, vol.369, pp.2042-2049, 2007.

K. P. Cain, K. D. Mccarthy, and C. M. Heilig, An algorithm for tuberculosis screening and diagnosis in people with HIV, N Engl J Med, vol.362, pp.707-716, 2010.

A. Cattamanchi, J. L. Davis, and W. Worodria, Sensitivity and specificity of fluorescence microscopy for diagnosing pulmonary tuberculosis in a high HIV prevalence setting, Int J Tuberc Lung Dis, vol.13, pp.1130-1136, 2010.

, Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MT, 2013.

, World Health Organization. Global tuberculosis report, 2013.

D. W. Dowdy, M. A. O'brien, and D. Bishai, Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis, Int J Tuberc Lung Dis, vol.12, issue.9, pp.1021-1029, 2008.

N. F. Sabur, A. Esmail, M. S. Brar, and K. Dheda, Diagnosing tuberculosis in hospitalized HIV-infected individuals who cannot produce sputum: is urine lipoarabinomannan testing the answer?, BMC Infect Dis, vol.17, p.29282005, 2017.

S. D. Lawn, A. D. Kerkhoff, M. Vogt, and R. Wood, Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral, Lancet Infect Dis, vol.12, issue.3, pp.70251-70252, 2012.

, Tuberculosis Diagnostics. Lateral Flow Urine Lipoarabinomannan Assay (LF-LAM) for the diagnosis and screening of active tuberculosis in people living with HIV, 2016.

M. Shah, C. Hanrahan, Z. Y. Wang, N. Dendukuri, S. D. Lawn et al., Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults, National AIDS Control Council. Kenya HIV estimates report, vol.14, issue.5, 2016.

H. Huerga, G. Ferlazzo, P. Bevilacqua, B. Kirubi, E. Ardizzoni et al., Incremental Yield of Including Determine-TB LAM Assay in Diagnostic Algorithms for Hospitalized and Ambulatory HIV-Positive Patients in Kenya, PLoS ONE, vol.12, issue.1, p.170976, 2017.

D. Husereau, M. Drummond, S. Petrou, C. Carswell, D. Moher et al., Good Reporting Practices Task Force Consolidated Health Economic Evaluation Reporting Standards (CHEERS)-Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force, Value in Health, vol.16, pp.231-250, 2013.

H. Autorité-de-santé, Choix méthodologiques pour l'é valuation é conomique à la HAS, HAS, 2011.

, Guide mé thodologique pour l'é valuation é conomique des stratégies de santé . Recommandations mé thodologiques, 2003.

N. Yakhelef, M. Audibert, F. Varaine, J. Chakaya, . Sitienei et al., Is introducing rapid culture into the diagnostic algorithm of smear-negative tuberculosis cost-effective?, The International Journal of Tuberculosis and Lung Disease, vol.18, issue.5, pp.541-546, 2014.
URL : https://hal.archives-ouvertes.fr/halshs-00991625

, National Institute for Health and Care Excellence, 2013.

. Ville-municipale-de-lyon, Nomenclature de l'amortissement des immobilisations

J. M. Melse, M. L. Essink-bot, P. G. Kramers, and N. Hoeymans, A national burden of disease calculation: Dutch disability-adjusted life-years. Dutch Burden of Disease Group, Am J Public Health, vol.90, pp.1241-1247, 2000.

J. A. Salomon, T. Vos, D. R. Hogan, M. Gagnon, M. Naghavi et al., Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study, Lancet, vol.380, issue.12, pp.61680-61688, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00921564

, World Health Organization

S. Ramsey, R. Willke, A. Briggs, R. Brown, M. Buxton et al., Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report, Value in Health, vol.8, issue.5, p.16176491, 2005.

M. F. Drummond, M. J. Sculpher, G. W. Torrance, B. J. O'brien, and G. L. Stoddart, Methods for the economic evaluation of health care programme, 2005.

, GNI per capita Kenya, currency USD, 2013.

, World Health Organization. Choosing interventions that are cost-effective

, Geneva: WHO, 2014.

, World Health Organization. WHO Guide to Cost-effectiveness Analysis, 2013.

J. N. Sekandi, K. Dobbin, J. Oloya, A. Okwera, C. C. Whalen et al., Cost-effectiveness analysis of community active case finding and household contact investigation for tuberculosis case detection in urban Africa, PLoS One, vol.10, issue.2, 2015.

R. Hutubessy, D. Chisholm, and T. T. Edejer, Generalized cost-effectiveness analysis for national-level priority-setting in the health sector, Cost Eff Resour Alloc, vol.1, issue.1, 2003.

P. Doubilet, C. B. Begg, M. C. Weinstein, P. Braun, and B. J. Mcneil, Probabilistic sensitivity analysis using Monte Carlo simulation: A practical approach, Medical Decision Making, vol.5, pp.157-177, 1985.

H. A. Glick, A. H. Briggs, and D. Polsky, Quantifying stochastic uncertainty and presenting results of cost-effectiveness analyses, Exp Rev Pharmacoecon Outcomes Res, vol.1, pp.25-36, 2001.

B. J. O'brien and A. H. Briggs, Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods, Statistical Methods in Medical Research, vol.11, issue.6, pp.455-468, 2002.

W. C. Black, The CE plane: a graphic representation of cost-effectiveness, Med Decis Making, vol.10, issue.26, pp.212-214, 1990.

E. Fenwick, K. Claxton, and M. Sculpher, Representing uncertainty: The role of cost-effectiveness acceptability curves, Health Economics, vol.10, pp.779-787, 2001.

D. J. Cohen and M. R. Reynolds, Interpreting the Results of Cost-Effectiveness Studies, J Am Coll Cardiol, vol.52, issue.25, pp.2119-2126, 2008.

A. Garber and C. Phelps, Economic foundations of cost-effectiveness analysis, J Heal Econ, vol.16, issue.1, pp.1-31, 1997.

, Chest radiography in tuberculosis detection. Summary of current WHO recommendations and guidance on programmatic approaches, 2016.

S. D. Shillcutt, D. G. Walker, C. A. Goodman, and A. J. Mills, Cost-Effectiveness in Low-and Middle-Income Countries. A Review of the Debates Surrounding Decision Rules, Pharmacoeconomics, vol.27, issue.11, pp.903-917, 2009.

M. Shah, W. Ssengooba, D. Armstrong, L. Nakiyingi, M. Holshouser et al., Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals with suspected tuberculosis in Uganda, AIDS, vol.28, issue.9, pp.1307-1314, 2014.

D. Sun, S. Dorman, M. Shah, Y. C. Manabe, V. Moodley et al., Cost-Utility of Lateral-Flow Urine Lipoarabinomannan for Tuberculosis Diagnosis in HIV-infected African Adults, Int J Tuberc Lung Dis, vol.17, issue.4, pp.552-558, 2013.

K. P. Reddy, A. Gupta-wright, K. L. Fielding, S. Constantini, A. Zheng et al., Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study, Lancet Global Health, 2019.